(Q40628186)

22 September 2017

title

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity (English)

1 reference

22 September 2017

main subject

phase I clinical trial

0 references

1 reference

Dilts DA

1

1 reference

22 September 2017

Riesenfeld-Orn I

2

1 reference

22 September 2017

Fulginiti JP

3

1 reference

22 September 2017

Ekwall E

4

1 reference

22 September 2017

Granert C

5

1 reference

22 September 2017

Nonenmacher J

6

1 reference

22 September 2017

Brey RN

7

1 reference

22 September 2017

Cryz SJ

8

1 reference

22 September 2017

Karlsson K

9

1 reference

22 September 2017

Bergman K

10

1 reference

22 September 2017

Thompson T

11

1 reference

22 September 2017

Hu B

12

1 reference

22 September 2017

Brückner AH

13

1 reference

22 September 2017

Lindberg AA

14

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

22 September 2017

1 reference

22 September 2017

volume

18

1 reference

22 September 2017

issue

15

1 reference

22 September 2017

page(s)

1473-1484

1 reference

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Construction of genetically defined double aro mutants of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Construction of delta aroA his delta pur strains of Salmonella typhi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

A New Method for the Extraction of R Lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Electrodialysis of Lipopolysaccharides and Their Conversion to Uniform Salt Forms

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Oral Delivery of Antigens in Live Bacterial Vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

The role of a stress-response protein in Salmonella typhimurium virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

The human humoral immune response to Salmonella typhi Ty21a.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Progress in vaccines against typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

Attenuated, Streptomycin-Dependent Salmonella typhi Oral Vaccine: Potential Deleterious Effects of Lyophilization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

The RcsB-RcsC regulatory system of Salmonella typhi differentially modulates the expression of invasion proteins, flagellin and Vi antigen in response to osmolarity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900424-7

7 January 2021

10.1016/S0264-410X(99)00424-7

Identifiers

DOI

1 reference

22 September 2017

1 reference